On Aug 22, Livingstone Health Holdings : PRH 0% executive director and CEO Wilson Tay Ching Yit acquired 92,000 shares of the Catalist-listed company at an average price of 11.6 cents per share. With a consideration of S$10,672, this increased Dr Tay&rsquo s total interest in the multidisciplinary healthcare group from 58.53 per cent to 58.55 per cent.

 

Between Aug 15 and 16, Livingstone Health Holdings : PRH 0% executive director and CEO Wilson Tay Ching Yit acquired 200,000 shares of the Catalist-listed company at an average price of 11.9 cents per share.

 

With a consideration of S$23,800, this increased his total interest in the multidisciplinary healthcare group from 58.48 per cent to 58.53 per cent.

 

Dr Tay specialises in anesthesiology, has 16 years of clinical experience, and is responsible for the overall strategic direction and development of the group.

 

On May 31, Livingstone Health Holdings : PRH -5.37% executive director and CEO, Wilson Tay, acquired 160,100 shares of the company for a consideration of S$22,244.

 

At an average price of 13.9 cents per share, this increased his total interest in the multidisciplinary healthcare group from 58.43 per cent to 58.47 per cent.

 

Dr Tay specialises in anaesthesiology with 15 years of clinical experience, and he is responsible for the overall strategic direction and development of the group.